“…For more than a decade, active pharmaceutical ingredients as organic salts and ionic liquids (API-OSILs) have risen in academia as an alternative formulation for low bioavailable drugs [9][10][11][12]. This third generation of ionic liquids [9] consists on the combination of APIs as cations or anions with organic counterions, thereby inducing distinctive physicochemical properties over the original drugs and reduced toxicity to healthy cells, thus rendering a potentially enhanced pharmaceutical activity in comparison to the API [13][14][15][16][17][18][19][20][21][22][23][24][25]. Our works involving the preparation of API-OSILs from, e.g., β-lactam (ampicillin [18][19][20][21], penicillin [22] and amoxicillin [22]) and fluoroquinolone [18,23] antibiotics, NSAIDs (ibuprofen [17,18], naproxen [18]), bone antiresorptive agents (zoledronic [24] and alendronic [25] acids), among others, have shown that the combination of an API, either as a cation or as an anion, with suitable biocompatible counter-ions can increase the water solubility of the parent drug and even change its biological effect [10,17,[23][24][25][26][27][28].…”